Always discuss medical weight-loss treatment with a qualified healthcare provider
The current pharmacology literature does not show direct CYP-mediated interactions between CBD and semaglutide, tirzepatide, or liraglutide
Once youre consistent with those, add in more
The evidence base derives primarily from clinical trials examining metabolic outcomes in patients with type 2 diabetes or obesity, many of whom had concurrent NAFLD
Know that in Kenner, oral semaglutide clinics are committed to facilitating access to this effective treatment
35%) Shoden is the most potent and bioavailable of the top three branded extracts, boasting a 35% withanolide glycoside concentration.25 Supporting this, Shoden is most likely the commercially available 35% extract that performed significantly better than the smaller extracts in the previously mentioned 2025 bioavailability study